India Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Product Code GMD10106
Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 99
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

India Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to India diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in India

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in India.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in India.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Keywords

India Diabetes Care Devices, India Glucose Monitoring, India Blood Glucose Meters, India Blood Glucose Test Strips,India Insulin Delivery ,India Insulin Jet Injectors,India Insulin Pens,India Insulin Pumps,India Insulin Syringes, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, LifeScan, Inc., Abbott Laboratories, Bayer HealthCare AG, Becton, Dickinson and Company, Eli Lilly and Company, Medtronic, Inc., ARKRAY, Inc., Terumo Corporation,

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Diabetic Care Devices
    • 3.2 Glucose Monitoring Devices
      • 3.2.1 Blood Glucose Meters
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Pens
      • 3.3.2 Insulin Syringes
      • 3.3.3 Insulin Pumps
      • 3.3.4 Traditional Insulin Pump Accessories
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
      • 4.2.1 Healthcare Personnel Data
      • 4.2.2 Healthcare Facilities Data
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval
    • 5.2 Central Drugs Authority of India (CDAI)
    • 5.3 Medical Device Regulatory Authority of India (MDRAI)
    • 5.4 Classification of medical devices
      • 5.4.1 Registration Period
  • 6 Pricing and Reimbursement
    • 6.1 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Diabetes Care Devices In India
    • 8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Diabetes Care Devices, India, Overall Revenue ($ mn), 2000-2015
    • 8.3 Diabetes Care Devices, India, Category Volume (Units), 2000-2015
    • 8.4 Diabetes Care Devices, India, Company Share (2007-2008)
  • 9 Glucose Monitoring In India
    • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
    • 9.2 Glucose Monitoring Overall Volume (2000-2015)
    • 9.3 Glucose Monitoring Average Price (2000-2015)
    • 9.4 Glucose Monitoring Distribution Share (2007-2008)
    • 9.5 Glucose Monitoring, India, Company Share (2007-2008)
  • 10 Insulin Delivery In India
    • 10.1 Insulin Delivery Overall Revenue (2000-2015)
      • 10.1.1 Insulin Pens Overall Revenue (2000-2015)
    • 10.2 Insulin Delivery Overall Volume (2000-2015)
      • 10.2.1 Insulin Pens Overall Volume (2000-2015)
    • 10.3 Insulin Delivery Average Price (2000-2015)
    • 10.4 Insulin Delivery Distribution Share (2007-2008)
    • 10.5 Insulin Delivery, India, Company Share (2007-2008)
  • 11 Overview of Key Companies in India Diabetes Care Devices Market
    • 11.1 Becton, Dickinson and Company
      • 11.1.1 Company Overview
      • 11.1.2 Value Chain Analysis
    • 11.2 F. Hoffmann-La Roche Ltd
      • 11.2.1 Company Overview
      • 11.2.2 Value Chain Analysis
      • 11.2.3 F. Hoffmann-La Roche Ltd Pipeline Products
    • 11.3 Novo Nordisk A/S
      • 11.3.1 Company Overview
      • 11.3.2 Novo Nordisk A/S Pipeline Products
    • 11.4 Hindustan Syringes & Medical Devices Ltd
      • 11.4.1 Company Overview
    • 11.5 Sanofi-Aventis
      • 11.5.1 Company Overview
    • 11.6 Eli Lilly and Company
      • 11.6.1 Company Overview
      • 11.6.2 Value Chain Analysis
      • 11.6.3 Eli Lilly and Company Pipeline Products
    • 11.7 Bayer HealthCare AG
      • 11.7.1 Company Overview
      • 11.7.2 Value Chain Analysis
      • 11.7.3 Bayer HealthCare AG Pipeline Products
    • 11.8 LifeScan, Inc
      • 11.8.1 Company Overview
      • 11.8.2 LifeScan, Inc. Pipeline Products
    • 11.9 Abbott Laboratories
      • 11.9.1 Company Overview
      • 11.9.2 Value Chain Analysis
      • 11.9.3 Abbott Laboratories Pipeline Products
    • 11.10 Medtronic, Inc
      • 11.10.1 Company Overview
      • 11.10.2 Value Chain Analysis
      • 11.10.3 Medtronic, Inc. Pipeline Products
    • 11.11 ARKRAY, Inc
      • 11.11.1 Company Overview
      • 11.11.2 ARKRAY, Inc. Pipeline Products
    • 11.12 Terumo Corporation
      • 11.12.1 Company Overview
      • 11.12.2 Value Chain Analysis
    • 11.13 Animas Corporation
      • 11.13.1 Company Overview
    • 11.14 Apex Biotechnology Corp
      • 11.14.1 Company Overview
    • 11.15 Carewell Biotech Pvt. Ltd
      • 11.15.1 Company Overview
  • 12 Recent Developments
    • 12.1 Government and Public Interest
      • 12.1.1 May 19, 2009: Piramal Launches Trial Material Packaging Capacity In UK
    • 12.2 Product News
      • 12.2.1 Mar 02, 2009: Generex To Present Oral-Lyn At International Conference On Advances In Diabetes And Insulin Therapy
  • 13 Appendix
    • 13.1 Global Markets Direct Research Methodology
    • 13.2 Coverage
    • 13.3 Secondary Research
    • 13.4 Primary Research
    • 13.5 Models
    • 13.6 Forecasts
    • 13.7 Expert Panel Validation
    • 13.8 Currency Conversion
    • 13.9 Contact Us
    • 13.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctors by Specialty in India, 2000-2006
    • Table 2: Wards by Specialty in India, 2000-2006
    • Table 3: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 4: Diabetes Care Devices, India, Overall Revenue ($ mn), 2000-2015
    • Table 5: Diabetes Care Devices, India, Cross-Category Analysis, 2000-2015
    • Table 6: Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 7: Diabetes Care Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 8: Diabetes Care Devices, India, Category Volume (Units), 2000-2015
    • Table 9: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2008
    • Table 10: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2008-2015
    • Table 11: Diabetes Care Devices, India, Company Share by Revenue ($ mn), 2007-2008
    • Table 12: Glucose Monitoring, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 13: Glucose Monitoring, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 14: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2000-2008
    • Table 15: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 16: Glucose Monitoring, India, Average Price ($), Historic, 2000-2008
    • Table 17: Glucose Monitoring, India, Average Price ($), Forecast, 2008-2015
    • Table 18: Glucose Monitoring, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 19: Glucose Monitoring, India, Company Share by Revenue ($ mn), 2007-2008
    • Table 20: Insulin Delivery, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 21: Insulin Delivery, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 22: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 23: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 24: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2000-2008
    • Table 25: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 26: Insulin Pens, India, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 27: Insulin Pens, India, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 28: Insulin Delivery, India, Average Price ($), Historic, 2000-2008
    • Table 29: Insulin Delivery, India, Average Price ($), Forecast, 2008-2015
    • Table 30: Insulin Delivery, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 31: Insulin Delivery, India, Company Share by Revenue ($ mn), 2007-2008
    • Table 32: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 33: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 34: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
    • Table 35: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 36: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 37: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 38: Novo Nordisk A/S Pipeline Products By Clinical Trials
    • Table 39: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 40: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 41: Eli Lilly and Company Pipeline Products by Therapy Area
    • Table 42: Eli Lilly and Company Pipeline Products by Clinical Trials
    • Table 43: Eli Lilly and Company Pipeline Products by News Summary
    • Table 44: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 45: Bayer HealthCare AG Pipeline Products by Development Stage
    • Table 46: Bayer HealthCare AG Pipeline Products by Therapy Area
    • Table 47: Bayer HealthCare AG Pipeline Products by News Summary
    • Table 48: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 49: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 50: LifeScan, Inc. Pipeline Products by Therapy Area
    • Table 51: LifeScan, Inc. Pipeline Products by Clinical Trials
    • Table 52: LifeScan, Inc. Pipeline Products by News Summary
    • Table 53: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 54: Abbott Laboratories Pipeline Products by Development Stage
    • Table 55: Abbott Laboratories Pipeline Products by Therapy Area
    • Table 56: Abbott Laboratories Pipeline Products by Clinical Trials
    • Table 57: Abbott Laboratories Pipeline Products by News Summary
    • Table 58: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 59: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 60: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 61: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 62: Medtronic, Inc. Pipeline Products By News Summary
    • Table 63: ARKRAY, Inc. Pipeline Products by Equipment Type
    • Table 64: ARKRAY, Inc. Pipeline Products by Development Stage
    • Table 65: ARKRAY, Inc. Pipeline Products by Clinical Trials
    • Table 66: ARKRAY, Inc. Pipeline Products by News Summary
    • Table 67: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in India, 2000-2005
    • Figure 2: Private Expenditure on Health by Source, 2005
    • Figure 3: Proposed Medical Equipment Classification in India, 2005
    • Figure 4: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 5: Diabetes Care Devices, India, Overall Revenue ($ mn), 2000-2015
    • Figure 6: Diabetes Care Devices, India, Cross-Category Analysis, 2000-2015
    • Figure 7: Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 8: Diabetes Care Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 9: Diabetes Care Devices, India, Category Volume (Units), 2000-2015
    • Figure 10: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2008
    • Figure 11: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2008-2015
    • Figure 12: Diabetes Care Devices, India, Company Share (%), 2008
    • Figure 13: Glucose Monitoring, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 14: Glucose Monitoring, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 15: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 16: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 17: Glucose Monitoring, India, Company Share (%), 2008
    • Figure 18: Insulin Delivery, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 19: Insulin Delivery, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 20: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 21: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 22: Insulin Pens, India, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 23: Insulin Pens, India, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 24: Insulin Delivery, India, Company Share (%), 2008
    • Figure 25: Becton, Dickinson and Company Value Chain Analysis
    • Figure 26: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 27: Eli Lilly and Company Value Chain Analysis
    • Figure 28: Bayer HealthCare AG Value Chain Analysis
    • Figure 29: Abbott Laboratories Value Chain Analysis
    • Figure 30: Medtronic, Inc. Value Chain Analysis
    • Figure 31: Terumo Corporation Value Chain Analysis
    • Figure 32: Global Markets Direct Methodology